Psychiatr. pro Praxi, 2003; 3: 134-137

Liečba úzkostne-depresívnej poruchy buspironom

MUDr. Radovan Vaškovský
Psychiatrické oddelenie, Fakultná nemocnica Nitra

Published: December 31, 2003  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vaškovský R. Liečba úzkostne-depresívnej poruchy buspironom. Psychiatr. praxi. 2003;4(3):134-137.

Príspevok je zameraný na riešenie ovplyvnenia a možnosti liečby jedných z pomerne najčastejších duševných porúch, s ktorými sa stretávame v ambulantnej praxi. Poskytuje prehľad dvoch na sebe nezávislých sledovaní liečby skupiny pacientov s úzkostne-depresívnou poruchou a hodnotí trojmesačné sledovanie účinnosti ambulantnej liečby buspironom u pacientov so spomínaným ochorením.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Cohn JB, Rickels K. A pooled, double-blind comparison of the effects of buspirone, diazepam and placebo in women with chronic anxiety. Curr. Med. Res. Opin., 1989, 11; 304. Go to original source... Go to PubMed...
    2. Eison AS, Temple DL Jr. Buspirone: Review of its pharmacology and current perspectives on its mechanism of action. Amer. J. Med., 80 (Suppl. 3B), 1986; 1-9. Go to original source... Go to PubMed...
    3. Enkelman R. Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder. Psychopharmacology, 105, 1991; 428-432. Go to original source... Go to PubMed...
    4. Gelenberg AJ: Academic Highlights - buspirone: Seven years update. J Clin Psychiatry, 1994; 55: 222-229.
    5. Goldberg HL, Pinnerty RJ. The comparative efficacy of buspirone and diazepam in the treatment of anxiety. Amer J Psychiatry, 1997; 136: 1184-1187. Go to original source...
    6. Hőschl C, Libiger J, Švestka J. Psychiatrie. 2002: 855 s.
    7. Jann MW. Buspirone: An update on a unique anxiolytic agent. Pharmacotherapy, 1988, 8, 2; 100-116. Go to original source... Go to PubMed...
    8. Lader M. Psychological effect of buspirone. J Clin Psychiatry, 1982; 43, 12, (Sec. 2); 62-67.
    9. Mattila M, Seppala T, Mattila MJ. Combined effects of buspirone and diazepam on objektive and subjektive tests on performance in healthy volunters. Clin Pharmacol Ther, 1986; 40: 620-626. Go to original source... Go to PubMed...
    10. Moskowitz H, Smiley A. Effects of chronically administered buspirone and diazepam on driving-related skills performance. J Clin Psychiatry, 1982; 43: 45-55.
    11. New JS. The discovery and development of buspirone: a new approach to the treatment of anxiety. Med res rev 1990; 101: 283-326. Go to original source... Go to PubMed...
    12. Newton RS, Marunycz JD, Alderdice MT, et al. Review of the side-effect profile of buspirone. Amer J Med, 1986; 80, (Suppl 3B): 17-21. Go to original source... Go to PubMed...
    13. Rickels K. Buspirone in clinical practice. J Clin Psychiatry 1990; 51 (9,suppl): 51-54.
    14. Sramek JJ, Frankiewics EJ, Cutler NR. Efficacy and safety of two dosing regimen in the treatment of outpatients with persistent anxiety. Clin Ther 1997; 19, 23: 498-506. Go to original source... Go to PubMed...
    15. Sramek JJ, Tansman M, Suri A, et al: Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms. J Clin Psychiatry, 1996; 57, 7: 287-291.
    16. Steinberg JR. Anxiety in elderly patients: a comparison of azapirones and benzodizepines. Drugs Aging 1994; 5: 335-345. Go to original source... Go to PubMed...
    17. Sussman N. Treatment of anxiety with buspirone. Psychiatric An, 1987; 17: 114-118. Go to original source...
    18. Sussman N. Switching patients from benzodiazepines to buspirone. Drug therapy, 1990 (suppl); 58-65.
    19. Vaškovský R. Improvment of mental diseases with anxiety symptoms by treatment with buspirone. CINP, Budapest, 25th - 29th September 2001.

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.